1. Home

Financial Disclosures

SSO 2022 International Conference on Surgical Cancer Care
Featuring Advanced Cancer Therapies
March 10-12, 2022

Disclosures Policy and Disclosures

As required by the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all planners, reviewers, presenters, instructors, moderators, authors, and other individuals in a position to control or influence the content of an activity must disclose ALL financial relationships with any ineligible company that have occurred within the past 24 months. Ineligible companies are those that cannot be accredited in the ACCME System and whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All identified conflicts of interest must be resolved, and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the SSO.

The following SSO 2022 International Conference on Surgical Cancer Care Featuring Advanced Cancer Therapies Faculty Presenters, Moderators, Planners, Reviewers, Abstract Presenters, Oral Abstract First Authors, and staff have disclosed financial relationship(s) with an ineligible company.

All identified conflicts of interest have been resolved.

Abigail Caudle (Moderator)        
Research Support: EndoMag      

Adel Kardosh (Presenter)            
Advisor or review panel member: Astellas Pharma Inc.; Advisor or Review Panel Member: Eisai Co., Ltd; Research Grant or Support: Natera            

Ali Ahmad (Abstract Presenter)
Speaker/Honoraria: Intuitive Surgical     

Aimee Crago (Reviewer)
Advisor or Review Panel Member: Springworks Therapeutics

Alessandro Gronchi (Reviewer)
Advisor or Review Panel Member: Bayer HealthCare Pharmaceuticals Inc.; Advisor or Review Panel Member: Eli Lilly (Status: Terminated --- 2020), Novartis (Status: Terminated --- 2020); Speaker/Honoraria: Nanobiotix (Status: Terminated --- 2020); Advisor or Review Panel Member: Pfizer (Status: Terminated --- 2019); Advisor or Review Panel Member, Research Support, Speaker/Honoraria: PharmaMar; Advisor or Review Panel Member: SpringWorks     

Anees Chagpar (Presenter)         
Consultant: Athenex, Guardant Health, Inc., Lumicell, Novartis, Puma Therapeutics, Sanofi Aventis; Advisor or Review Panel Member: Protean Biodiagnostics

Aparna Parikh (Reviewer)
Research Support: Bristol Myers Squibb, Daiichi sankyo, Genentech, Miratim, Novartis, Plexxicon, PMV, PureTech; Research Support, Advisor or Review Panel Member, Equity, Ownership Interest: C2i Genomics; Consultant: Eli Lilly; Scientific Oversight Committee: Genentech/Roche; Advisor or Review Panel Member: Inivata, Pfizer; 11. Plexxicon; 12.                

Bridget Fahy (Reviewer)
Stockholder: Align Tech, Inc, Bristol Myers Squibb, Dava Oncology, Illumina, Inc., Imedex, LLC,  MedIummune, Merck & Co., Inc., Fulgent Genetics, GoodRx Holdings, Guardant Health, Inc., Healthequity Inc, Intuitive Surgical, INVITAE CORP, Masimo, Moderna, Neurocrine Bioscience, Novocure Ltd, Qidel, Repligen Corp, ResMed Inc, Seagen, Shockwave Medical, Staar Surgical Co, Teladoc Health, United Healthcare, Veeva Systems Inc             

Carlos Chan (Reviewer, Abstract Presenter)        
Research Support: Angiodynamics, Checkmate Pharmaceuticals

Carolyn Nessim (Reviewer)
Speaker/Honoraria: Merck (Status: Terminated --- Oct 14, 2021);  Advisor or Review Panel Member: Novartis (Status: Terminated --- Oct 15, 2020); Advisor or Review Panel Member: Sanofi Genzyme (Status: Terminated --- Dec 8 2020)

Cathy Eng (Panelist, Presenter)
Consultant: Bayer

Chandrajit Raut (Planner, Moderator)
Author: UpToDate; Royalties: UpToDate

Charlotte Ariyan (Moderator)    
Stockholder: AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Inc., Genentech, Inc, Immunomedics, Merck & Co., Pfizer Inc, Puma Biotechnology, Inc.

Ching-Wei Tzeng (Reviewer)
Consultant, Research Grant or Support: Panther

Christina Roland (Reviewer)
Research funding to institution, Research Grant or Support: Bristol Myers Squibb

Christina Laronga (Reviewer, Moderator)
Royalties: UpToDate

Danielle Bello (Abstract Presenter)         
Advisor of Review Panel Member: Philogen        

Darren Carpizo (Moderator)      
Ownership Interest: Z53 Therapeutics, Inc.

David Bartlett (Planner)
Speaker /Honoraria: Excite International, Inc. (Status: Terminated --- 8/2020)

David Hsieh (Panelist)
Research Support: Roche        

Douglas Tyler (Planner, Presenter, Moderator)  
Advisor or Review Panel Member: Castle Biosciences (Status: Terminated --- 11/22/20)

Edmund Bartlett (Presenter)      
Speaker/Honoraria: Excite International, Inc       
Edmund Bartlett (Presenter)
Speaker: Excite International, Inc.; Honoraria: Excite International, Inc.

Eiji Oki  (Abstract Presenter)      
Advisor or Review Panel member, Speaker/Honoraria: Bayer HealthCare Pharmaceuticals Inc., Eli Lilly; Speaker/Honoraria: Bristol Myers Squibb, CHUGAI PHARMACEUTICAL CO., LTD, ONO PHARMACEUTICAL CO., LTD., TAIHO PHARMACEUTICAL CO., LTD, Takeda Pharmaceutical Co., Ltd.; Advisor or Review Panel member: Guardant Health

Elizabeth Mittendorf (Abstract Presenter)           
Advisor or Review Panel member, Research Support: Exact Sciences/Genomic Health; Advisor or Review Panel Member: Genentech/Roche, Merck       

Emad Kandil (Reviewer, Moderator)       
Consultant: Taewoong  

Flavio Rocha (Reviewer)
Research Grant or Support: Gunze; Consultant: Medtronic

Genevieve Boland (Planner, Reviewer)
Stockholder: Ankyra Therapeutics; Research Grant or Support: InterVenn Bioscience, Merck; Advisor or Review Panel Member: Nektar Therapeutics; Advisor or Review Panel Member: Novartis (Status: Terminated); Research Grant or Support: Olink Proteomics, Palleon Pharmaceuticals        

Giorgos Karakousis (Planner, Presenter)
Investigator Initiated trial support (to Penn Institution), Research Grant or Support: Merck
           
Glen Balch (Presenter) 
Consultant: Cancer Expert Now; Research Grant or Support, Speaker/Honoraria: Intuitive Surgical; Ownership Interest: OncoNano; Consultant: Patient Resources           

Heather McArthur (Abstract Presenter)
Advisor or Review Panel Member, Consultant, Research Grant or Support: AstraZeneca; Research Grant or Support: Bristol Myers Squibb; Consultant: Eli Lilly & Company; Advisor or Review Panel Member, Research Grant or Support: Merck; Advisor or Review panel Member Puma Biotechnology, Inc., Seattle Genetics

Hisakazu Hoshi  (Planner, Moderator)    
Advisor or Review Panel Member: Castle Biosciences (Status: Terminated --- February 2021)

Hong Jin Kim (Presenter, Panelist, Reviewer)
Consultant: Ethicon Endosurgery, Inc.  (Status: Terminated --- 7/1/21)

Jason Sicklick (Presenter)            
Philanthropic Research Donation, Research Support: Amgen; Consultant, Speaker/Honoraria: Deciphera; Speaker/Honoraria: Foundation Medicine, Inc., La-Hoffman-Roche, Merck, MJH Life Sciences, QED Therapeutics; Stockholder: Personalis        

Jen Jen Yeh (Presenter, Panelist)              
Ownership/Co-Founder: Advanced Chemotherapy Technologies; Patent Holder: GeneCentric      

Joseph Kim (Presenter)
Research Support: Exelixis, Ipsen, Merck & Co.   

Joshua Mammen (Moderator)  
Advisor or Review Panel Member: United Healthcare

J. Joshua Smith (Reviewer)
Clinical Advisor: Guardant Health, Inc. (Status: Terminated – 2019)           
 
John Hyngstrom (Reviewer)
Consultant: Bristol Myers Squibb; Advisor or Review Panel Member: Nektar Therapeutics

Judy Boughey (Abstract Presenter, Reviewer)    
Data Safety Monitoring Committee: Cairns Surgical; Royalties: SymBioSis               

Julio Garcia-Aguilar (Presenter)
Speaker/Honoraria: Ethicon J&J; Consultant, Speaker/Honoraria, Stockholder: Intuitive Surgical; Consultant: Medtronic           

Kandace McGuire (Reviewer)
Advisor or Review Panel Member: Mammotome, Inc.

Karyn Stitzenberg (Moderator, Reviewer)            
Stockholder: CVS, Johnson & Johnson, Merck, Pfizer, United Healthcare, Vertex Pharma

Kelly Hunt (Reviewer)
Advisor or review panel Member: Armada Health; Research Grant or Support: CairnSurgical; Research Grant or Support: Lilly & Co., Lumicell

Kenneth Tanabe (Presenter, Panelist)
Consultant: American Cancer Society, Best Doctors, Cancer Experts, Innocoll, Leidos; Royalties: UpToDate

Lajos Pusztai (Presenter)             
Consultant, Research Support: AstraZeneca, Bristol Myers Squibb, Merck, Pfizer, Seagen; Consultant: Novartis.

Marie Catherine Lee (Reviewer, Planner, Moderator)     
Research Support: Elucent Medical         

Mark Cohen (Presenter)
Research Grant or Support: GigXR, Inc; Stockholder: HylaPharm, LLC; Research Grant or Support: Michigan Aerospace Corporation, Inc.; Advisor or Review Panel Member: Pathware, Inc.; Independent Contractor: Wideawake VR, Inc.               

Mark Faries (Abstract Presenter)             
Advisor or Review Panel Member: Merck Sharp & Dohme, Mektar Therapeutics, Novartis              

Matthew Kalady (Reviewer, Planner, Moderator)             
Advisor or Review Panel Member: Activ Surgical

Martin Heslin (Planner)
Independent Contractor: Best Doctors, Inc.

Melanie Lyden
Royalties: UpToDate (Status: Terminated)

Melissa Hogg (Moderator)
Research Support: Intuitive Surgical        

Michael Egger (Moderator)        
Consultant: Iovance Biotherapeutics; Research Support: SkylineDx           

Mihaela Druta (Presenter)          
Advisor or Review Panel Member: Deciphera     

Muhammed Murtaza (Presenter)            
Speaker/Honoraria: AstraZeneca; Consultant: Castle Biosciences; Patent Holder, Royalties: Exact Sciences, Inivata; Advisor or Review Panel Member, Ownership Interest, Stock Options: PetDx       

Nancy Demore (Planner)
Consultant, Patent Holder, Ownership Interest: Inova Therapeutics, Inc.

Nasreen Vohra (Reviewer, Moderator)  
Advisor or Review Panel member, Advisory Board Member: Castle Biosciences   

Oliver Eng (Moderator)
Stockholder: Aileron Therapeutics, Inc., Alpine immube Sciences, ALX Oncology Holdings Inc., Arbutus Biopharma, ARK Funds, Cerevel Therapeutics Holdings, Iovance Biotherapeutics, Mediwound Ltd, Novavax, Inc., Patham Pharmaceuticals Inc., Tarsus Pharmaceuticals Inc, Veru Inc., Zymeworks Inc.        

Olivier Glehen (Presenter)          
Consultant: Gamida       

Patti Stella (Staff)
Stockholder: Horizon Pharmaceutical PLC, SPDR BioTech (XBI), Intuitive Surgical
 
Rebecca Auer (Abstract Presenter, Presenter)    
Research Gant or Support: Leo Pharma Inc.         

Russell Langan (Planner)
Consultant: Eon, Mobilesmith

Sam Yoon (Abstract Presenter) 
Ownership Interest: Attis Lab     

Shelley Hwang   (Abstract Presenter)      
Consultant: Astra Zeneca, Immunis; Steering Committee: Clinetic, Higgs Boson; Speakers' Bureau: Merck

Shishir Maithel  (Presenter, Panelist)      
Research Grant or Support: Celgene (BMS), QED / HELSINN

Steven Nurkin (Planner)
Speaker Honoraria: Merck (Status: Terminated – 6/29/2021)
             
Suzanne Topalian (Presenter)    
Consultant: Amgen, AstraZeneca, Janssen Pharmaceuticals, Shattuck Labs, Tempest Therapeutics; Consultant, Research Support, Royalties: Bristol Myers Squibb;  Consultant, Research Support: Compugen; Stock options, Stockholder: DNAtrix Therapeutics; Stockholder: Dracen Pharmaceuticals; Consultant, Stock options, Stockholder: Dragonfly Therapeutics;  Research Support, Stockholder: Enara Bio; Consultant, Stockholder: Five Prime Therapeutics; Consultant Royalities:  Immunocore, Immunomic Therapeutics; Stockholder: MannaT Bio; Consultant, Stock Options, Stockholder: RAPT Therapeutics; Stockholder: Tieza; Consultant, Stockholder: Tizona; Stockholder: TRex Bio Ltd; Consultant, Patent Holder, Stockholder: WindMIL            

Tawnya Bowles (Reviewer)
Research Grant or Support: Amgen, Asana Biosciences, LLC, Bristol Myers Squibb, Merck & Co., Novartis Phamaceuticals Corp., Replimune Group Inc., Genentech             

Teresa Kim (Panelist)     
Stockholder: Vertex Pharma

Timothy Donahue (Planner)
Consultant: Interscope (Status: Terminated --- 1/2021); Speaker/Honoraria: PrecisCa; Stock Options: Trethera Corporation

Tina Hieken (Presenter, Abstract Presenter, Reviewer)   
Research Support: Genentech, SkylineDx             

Uma Phatak (Reviewer)
Attended a dinner: Da Vinci Surgery
 
William Rilling (Presenter)          
Consultant; Advisor or Review Panel Member: BD/Bard; Consultant, Research Grant or Support: Boston Scientific; Consultant: Sirtex, Terumo, Varian          

Yuman Fong (Presenter)
Consultant: Covidien Inc., Eureka, Iovance Biotherapeutics, Medtronic, Theromic, Vergent; Advisor or Review Panel Member, Royalties: Imugene; Royalties: Merck; Advisor or Review Panel Member: Sangam          

All other SSO 2022 International Conference on Surgical Cancer Care Featuring Advanced Cancer Therapies Faculty Presenters, Moderators, Planners, Reviewers, Oral Abstract Presenters Oral Abstract First Authors, and staff disclosed they have no relevant financial relationship(s) with an ineligible company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.